Skip to main content
. 2017 Jul;18(7):929–945. doi: 10.1016/S1470-2045(17)30404-7

Table 7.

Risk of disease recurrence by nodal status in trials of dose-dense chemotherapy

Node negative 1–3 nodes >3 nodes
TACT2 1·00 (0·78–1·28) 0·87 (0·69–1·09) 0·97 (0·72–1·30)
GIM215* N/A 0·88 (0·67–1·11) 0·68 (0·54–0·86)
AGO ETC17 N/A N/A 0·72 (0·59–0·87)

Data are hazard ratios (95% CI) for the primary endpoint (recurrence) by nodal subgroups. N/A=not applicable.

*

Data supplied by authors on request; similar data for CALGB 9741 were unavailable.